India's Pharmaceutical Exports

Country Profile

Canada

Canada is a major destination for Indian pharmaceutical exports — $629M in FY 2025–26, with 3.1× growth over the past decade. Medicines accounts for 86% of shipments, with vaccines contributing $1.74M. The compound annual growth rate since FY2015 stands at 11.0%.

🇨🇦 #10 Destination · $629M · 3.1× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$629M
Exports FY2025–26 DGCIS
3.1×
Growth FY2015→2026
2.0%
Share of India Total
#10
Rank Among 178 Markets
11.0%
CAGR FY2015→2026
Canada is a major destination for Indian pharmaceutical exports — $629M in FY 2025–26, with 3.1× growth over the past decade. Medicines accounts for 86% of shipments, with vaccines contributing $1.74M. The compound annual growth rate since FY2015 stands at 11.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $541M (86.0%) Medicine Ingredients $70.1M (11.1%) Traditional & Herbal $12.4M (2.0%) Surgical & Hospital Supplies $3.64M (0.6%) Vaccines $1.74M (0.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Canada in the RBI overseas direct investment dataset (2011–2026).